Putting the patient first
Patients are now better informed about their health and highly involved in making decisions about their treatment. As pharmaceutical companies strive to become more patient-centric, there is a need for them to develop the same strong understanding of the patient as they have of the physician.
We offer both custom and syndicated solutions to improve patient understanding.
To facilitate the move towards greater patient centricity we can help with:
Complete understanding of the patient journey from pre-diagnosis to stabilisation, covering the healthcare, disease, emotional and digital pathways, identifying the roadblocks to successful outcomes
Research involving all relevant stakeholders, including physicians, other healthcare professionals, advocacy groups, payers, patients and caregivers, employing observational and behavioural economic techniques to recreate the real-world experience
Research with patients at earlier stages in the product lifecycle, such as in clinical trial design or early-stage market understanding
Recruitment and research with hard-to-reach patients, such as those with rare diseases, or those patients at later stages in their disease, as well as those with long-term chronic conditions
Mobile and digital ethnographic approaches to get you closer to the patient and capture insights in-the-moment
Patient willingness to pay in countries where healthcare expenditure can be out-of-pocket such as the US and emerging markets
Patient segmentation research in order to understand the characteristics of specific groups of patients to target for disease awareness, communication and around the pill support initiatives
Find out more about our customised patient research expertise via our free online resources and find out more about “Living with”, our syndicated patient research reports across a range of chronic diseases and global markets by clicking the boxes below.
- Some example case studiesHow we applied user-led design thinking in the ER setting to improve patient care
The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a burden and antibiotic resistance is a key issue, which sometimes results in families needing to seek emergency hospital attention in response to acute pain. We interviewed urgent care and ER physicians in order to find…read more »Review of Disease Promotion Campaign using Facial Analysis
The challengeOur client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign (rational and emotional) and whether it would have the desired effect of increasing use of their treatment in the future, to help encourage the client’s local operating companies to adopt and roll out the…read more »Backroom brainstorm
The challengeOur client had an oncology product in development for the treatment of prostate cancer. The company wanted to conduct research to inform future planning, list development, advisory board creation, and initial communications platforms. In an earlier quantitative wave of research we had identified four segments to define physician treatment and prescription behaviors. Our next challenge was to validate the segmentation. Our client wanted to…read more »
- Our latest webinarsPortfolio analysis: Making Go/No-Go decisions to optimise the portfolio
Tuesday 20th March 2018 12:00 EST / 16:00 GMT / 17:00 CESTread more »Webcast: Rich in potential - Exploring the opportunity for nutritionals in emerging markets
A shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories, attention is turning to emerging markets. Join Research Partnership's emerging market experts Paul Reed and Kira Pillai for our upcoming live webinar ‘Rich in potential: Exploring the opportunity for nutritionals in emerging markets’ in which they will…read more »Webcast: Portfolio tracking for success
Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line. Directors Tom Nolte and Melinda Shorr…read more »